Providing appropriate and affordable vaccines for the developing world
Influencing vaccine markets to the benefit of the poor has always been implicit in the GAVI mandate.
By aggregating and forecasting demand from countries and pooling donor funds, the Alliance has created a reliable market for vaccines in developing countries - providing an incentive for manufacturers to offer vaccines at prices poor countries can afford.
GAVI's market impact to date is evident in the drop in the price of pentavalent vaccine, the rise in the number of producers in emerging markets, the pneumococcal Advance Market Commitment (AMC) and the acceptance of a low-income pricing tier for vaccines, ie, manufacturers offering the same product to low-income countries at a lower price than that charged in high-income countries.
Goal-level indicatorsStrategic Objectives |
Market-shaping objectives
Given the Alliance's plans to widen its portfolio of vaccines, strategic goal four spells out two clear market-shaping objectives:
- ensure adequate supply to meet demand;
- minimise costs of vaccines to GAVI and countries.
Drawing on key partners such as the Accelerated Vaccine Introduction (AVI) Strategic Vaccine Supply sub-team and the UNICEF Supply Division, GAVI will aim to achieve its fourth strategic goal objectives through:
- continued strengthening and dissemination of forecasting to ensure credible signals to manufacturers;
- efficient and effective vaccine procurement and supply chain management;
- exploring innovative approaches to make demand more predictable, accelerate vaccine development, increase levels of production, and improve portfolio management.
